Nebulized Ketamine for the Treatment of Major Depressive Disorder
Nebulized Ketamine for the Treatment of Major Depressive Disorder
Recruiting · NCT06752759 · Registry updated 2026-04-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Nebulized Ketamine for the Treatment of Major Depressive Disorder | depressive disorder | Recruiting | Phase 3 | 2026-04-24 | NCT06752759 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Theresa Jacob, PhD, MPH | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Maimonides Medical Center | Brooklyn | United States | 68 |